Pulmotect's Series A Round

Pulmotect raised a round of funding on April 14, 2016. Investors include Fannin Innovation Studio.

Pulmotect is a bio-pharmaceutical company that develops products (host-directed/pathogen-agnostic) to reduce morbidity and mortality in patients at risk of severe respiratory diseases.…

Articles about Pulmotect's Series A Round: